Participating Faculty: The Clinical and Psychosocial Impact of Peyronie's Disease

March 26, 2013
Laurence A. Levine, MD, FACS

Supplements and Featured Publications, The Clinical and Psychosocial Impact of Peyronie’s Disease, Volume 19, Issue 4 Suppl

This supplement was supported by Auxilium Pharmaceuticals, Inc.

This supplement to The American Journal of Managed Care provides an overview of Peyronie’s disease (PD), describes sexuality and well-being in patients with PD, discusses the identification and management of patients with PD, and highlights unmet needs in PD.

Faculty

Laurence A. Levine, MD, FACS

Professor of Urology

RUSH University Medical Center

Chicago, Illinois

Disclosures

Laurence A. Levine, MD, FACS

Consultant or paid advisory board: Actient Pharmaceuticals; Auxilium Pharmaceuticals, Inc; Coloplast

Honoraria and lecture fees: Auxilium Pharmaceuticals, Inc; Coloplast

Signed disclosures are on file at the office of The American Journal of Managed Care, Plainsboro, New Jersey.

Opinions expressed by authors, contributors, and advertisers are their own and not necessarily those of Clinical Care Targeted Communications, LLC, d/b/a Managed Care & Healthcare Communications, LLC, the editorial staff, or any member of the editorial advisory board. Clinical Care Targeted Communications, LLC, d/b/a Managed Care & Healthcare Communications, LLC, is not responsible for accuracy of dosages given in articles printed herein. The appearance of advertisements in this publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality, or safety. Clinical Care Targeted Communications, LLC, d/b/a Managed Care & Healthcare Communications, LLC, disclaims responsibility for any injury to persons or property resulting from any ideas or products referred to in the articles or advertisements.